Keck USC The USC Peter A. Singer Thyroid Symposium 2024

+ Target Audience: endocrinologist + Information: The USC Peter A. Singer Thyroid Symposium returns for 2024, continuing our dedication to providing a comprehensive and current update in the management of thyroid disease. This will again be a hybrid program, offering options for in-person or virtual attendance. Clinical care of patients with thyroid disorders continues to change and develop in complexity. In our 2024 edition, the following is highlighted: disparities in thyroid cancer care along with key areas for specialists and general providers alike: treatment of Graves’ disease, additional use of T3 medication, health practices for Hashimoto’s disease, evaluation of thyroid nodules, disparities in thyroid cancer care, active surveillance of thyroid cancer and management of lymph node recurrences, and thyroid disease in pregnancy. Forward-looking perspectives are presented on the most current state of thyroid medicine informed by evidenced-based management strategies, with sessions combining clinical experience, challenging cases, panel discussions, and audience questions to inform solutions to complex clinical scenarios.

1. • Provide optimal patient counseling and consideration for active surveillance for low-risk papillary thyroid cancer.
2. • Examine new evidence of T4 and T3 combination therapy for hypothyroidism and in what patients it might be used.
3. • Distinguish advantages and disadvantaged between primary treatments for Graves’ Disease.
4. • Recognize areas of healthcare disparity in thyroid cancer care.
5. • Assess effectiveness of non-pharmaceutical and lifestyle measures of Hashimoto thyroiditis.
6. • Decide optimal timing and interventions for thyroid cancer lymph node metastases.
7. • Identify ultrasound findings that impact cancer risk for indeterminate thyroid nodules.
8. • Review current practice considerations for management of thyroid disease as it pertains to fertility.

  + Topics:

• Final_2024 Thyroid_Brochure.pdf Session 1 Graves’ Disease and Evaluating Thyroid Nodules- Q&A Session.mp4 Session 1 Graves’ Disease- Block It, Zap It, or Cut It Out..mp4 Session 1 Putting it All Together – Adding Sonographic Risk to the Evaluation of Indeterminate Thyroid Nodules.mp4 Session 1 Rethinking Hypothyroidism- Is Adding T3 the Way to Be.mp4 Session 1 Thyroid and Fertility- Q&A Session.mp4 Session 1 Thyroid and Fertility- We Have Questions. Are There Answers.mp4 Session 2 Disparities in Thyroid Cancer Care – Where Can We Improve..mp4 Session 2 Hashimoto’s and Thyroid Cancer- Q&A Session.mp4 Session 2 Health Practices for Hashimoto’s- Are There Measures that Matter..mp4 Session 3 Challenging Thyroid Cancer Cases from USC to the Panel.mp4 Session 3 Less is More- Active Surveillance In Low-Risk Papillary Thyroid Cancer.mp4 Session 3 Thyroid Cancer Surveillance and When to Operate- Q&A Session.mp4 Session 3 Timing is Everything- When to Operate for Thyroid Cancer Recurrence in the Neck.mp4 Syllabus.pdf